Partially matched, nonmyeloablative allogeneic transplantation : Clinical outcomes and immune reconstitutionRIZZIERI, David A; LIANG PIU KOH; NIEDZWIECKI, Donna et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 690-697, issn 0732-183X, 8 p.Article

Reduced-intensity conditioning or nonmyeloablative stem cell transplantation: Introduction, rationale, and historic backgroundSLAVIN, Shimon; EDITOR, Guest.Seminars in oncology. 2004, Vol 31, Num 1, pp 1-3, issn 0093-7754, 3 p.Article

Reduced-intensity conditioning regimens in malignant haematological diseasesBUFFART, T. E; JANSSEN, J. J. W. M; HUIJGENS, P. C et al.Netherlands journal of medicine. 2005, Vol 63, Num 2, pp 43-51, issn 0300-2977, 9 p.Article

Current status of haploidentical stem cell transplantationDEY, Bimalangshu R; SPITZER, Thomas R.British journal of haematology. 2006, Vol 135, Num 4, pp 423-437, issn 0007-1048, 15 p.Article

A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. CommentaryLE BLANC, Katarina; REMBERGER, Mats; UZUNEL, Mehmet et al.Transplantation. 2004, Vol 78, Num 7, pp 964-965, issn 0041-1337, 9 p.Article

Prognostic impact of serum ferritin concentration on survival following reduced-intensity conditioned allogeneic haemopoietic SCTOAKES, R; SOOD, Nitin; PEARCE, R et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 12, pp 1754-1755, issn 0268-3369, 2 p.Article

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosisCOOPER, Nichola; KANCHAN RAO; GILMOUR, Kimberly et al.Blood. 2006, Vol 107, Num 3, pp 1233-1236, issn 0006-4971, 4 p.Article

Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimenGOMEZ, E; DULERY, R; LANGLOIS, C et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 12, pp 1492-1497, issn 0268-3369, 6 p.Article

Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioningPREBET, T; DEVILLIER, R; FURST, S et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 10, pp 1574-1575, issn 0268-3369, 2 p.Article

Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioningUZUNEI, Mehmet; REMBERGER, Mats; SAIRAFI, Darius et al.Transplantation. 2006, Vol 82, Num 7, pp 913-919, issn 0041-1337, 7 p.Article

Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantationLAHAV, Meir; UZIEL, Orit; NAGLER, Arnon et al.Transplantation. 2005, Vol 80, Num 7, pp 969-976, issn 0041-1337, 8 p.Article

Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimensBANNA, Giuseppe Luigi; AVERSA, Savina; CHIARION SILENI, Vanna et al.Critical reviews in oncology/hematology. 2004, Vol 51, Num 3, pp 171-189, issn 1040-8428, 19 p.Article

Non-myeloablative stem cell transplantation for autoimmune diseasesBURT, Richard K; VERDA, Larissa; OYAMA, Yu et al.Springer seminars in immunopathology. 2004, Vol 26, Num 1-2, pp 57-69, issn 0344-4325, 13 p.Article

Establishment of Transplantation Tolerance via Minimal Conditioning in Aged RecipientsMORISON, J. K; HOMANN, J; HAMMETT, M. V et al.American journal of transplantation (Print). 2014, Vol 14, Num 11, pp 2478-2490, issn 1600-6135, 13 p.Article

Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomasSHUSTOV, Andrei R; GOOLEY, Theodore A; MALONEY, David G et al.British journal of haematology. 2010, Vol 150, Num 2, pp 170-178, issn 0007-1048, 9 p.Article

Reduced Intensity Transplantation for Primary Immunodeficiency DisordersVEYS, Paul.Immunology and allergy clinics of North America. 2010, Vol 30, Num 1, issn 0889-8561, 103-124, ix [23 p.]Article

The evolution of hematopoietic SCT in myelodysplastic syndromeKINDWALL-KELLER, T; ISOLA, L. M.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 8, pp 597-609, issn 0268-3369, 13 p.Article

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioningMASMAS, Tania N; PETERSEN, Søren L; MADSEN, Hans O et al.American journal of hematology. 2008, Vol 83, Num 7, pp 563-569, issn 0361-8609, 7 p.Article

The role of alemtuzumab in nonmyeloablative hematopoietic transplantationGIRALT, Sergio.Seminars in oncology. 2006, Vol 33, Num 2, issn 0093-7754, S36-S43, SUP5Article

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioningBARON, Frédéric; MARIS, Michael B; MALONEY, David G et al.Journal of clinical oncology. 2005, Vol 23, Num 9, pp 1993-2003, issn 0732-183X, 11 p.Article

Nonmyeloablative reduced-intensity transplantation in multiple myelomaANAGNASTOPOULOS, Athanasios; ALEMAN, Ana; GIRALT, Sergio et al.Seminars in oncology. 2004, Vol 31, Num 1, pp 33-36, issn 0093-7754, 4 p.Article

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomasCASTAGNA, L; BRAMANTI, S; BALZAROTTI, M et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 12, pp 1475-1480, issn 0268-3369, 6 p.Article

Développement des greffes haplo-identiques chez l'adulte atteint d'une hémopathie maligne = Advances in haploidentical transplantation in hematological malignanciesCASTAGNA, Luca; BLAISE, Didier.Bulletin du cancer. 2012, Vol 99, Num 12, pp 1141-1151, issn 0007-4551, 11 p.Article

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignanciesROSENTHAL, Joseph; WONG, Jeffrey; STEIN, Anthony et al.Blood. 2011, Vol 117, Num 1, pp 309-315, issn 0006-4971, 7 p.Article

Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experienceKRISHNAMURTHY, P; LIM, Z. Y; NAGI, W et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 10, pp 1502-1507, issn 0268-3369, 6 p.Article